{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Endpoints News"}, "author": "Andrew Dunn", "title": "Exclusive: Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones - Endpoints News", "description": "Isomorphic Labs, Alphabet\u2019s closely watched AI startup, has signed its first pharma partnerships, and will work with Eli Lilly and Novartis in deals that could be worth $3 billion, CEO Demis Hassabis exclusively told Endpoints News. Since its founding in Nove\u2026", "url": "https://endpts.com/alphabets-ai-unit-isomorphic-inks-drug-discovery-deals-with-eli-lilly-novartis-for-up-to-3b/", "urlToImage": "https://endpts.com/wp-content/uploads/2023/09/Demis-Hassabis-Isomorphic-tile.jpg", "publishedAt": "2024-01-07T17:00:00Z", "content": "Iso\u00admor\u00adphic Labs, Al\u00adpha\u00adbet\u2019s close\u00adly watched AI start\u00adup, has signed its first phar\u00adma part\u00adner\u00adships, and will work with Eli Lil\u00adly and No\u00advar\u00adtis in deals that could be worth $3 bil\u00adlion, CEO D\u2026 [+804 chars]"}]}